Research
Publications

Full list of publications 2014-2019

Verkarre V, Bibeau F [The inherited cancers, the pathologist]. Ann Pathol. 2020;40(2):61-62. doi:10.1016/j.annpat.2020.02.016

Cohen R, Pudlarz T, Garcia-Larnicol M-L, Vernerey D, Dray X, Clavel L, Jary M, Piessen G, Zaanan A, Aparicio T, Louvet C, Tournigand C, Chibaudel B, Tougeron D, Guimbaud R, Benouna J, Adenis A, Sokol H, Borg C, Duval A, Svrcek M, André T [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. Bull Cancer. 2020;107(4):438-446. doi:10.1016/j.bulcan.2019.11.016

Latorzeff I, Sargos P, Créhange G, Azria D, Hasbini A, Dubergé T, Toledano A, Graff-Cailleaud P, Chapet O, Hennequin C, de Crevoisier R, Supiot S, Pasquier D [Indications and outlooks of radiohormonal therapy of high-risk prostate cancers]. Cancer Radiother. Feb 11, 2020. doi:10.1016/j.canrad.2019.06.018

Maria A, Bourgier C, Martinaud C, Borie R, Rozier P, Rivière S, Crestani B, Guilpain P [From fibrogenesis towards fibrosis: Pathophysiological mechanisms and clinical presentations]. Rev Med Interne. Feb 08, 2020. doi:10.1016/j.revmed.2020.01.002

Adenis A, Samalin E, Mazard T, Portales F, Mourregot A, Ychou M [Does the FLOT regimen a new standard of perioperative chemotherapy for localized gastric cancer?]. Bull Cancer. Jan 21, 2020. doi:10.1016/j.bulcan.2019.12.005

Gros L, Paturel C, Perrot I, Bensussan A, Eliaou J-F, Bastid J, Bonnefoy N [A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response]. Med Sci (Paris). 2020;36(2):112-115. doi:10.1051/medsci/2020006

Mazieres J, Cropet C, Montané L, Barlesi F, Souquet P, Quantin X, Dubos-Arvis C, Otto J, Favier L, Avrillon V, Cadranel J, Moro-Sibilot D, Monnet I, Westeel V, Le Treut J, Brain E, Jaffro M, Collot S, Ferretti G, Tiffon C, Mahier-Ait Oukhatar C, Blay J Vemurafenib in non-small-cell lung cancer patients with BRAFV600 and BRAFnonV600 mutations. Ann. Oncol.. 2020;31(2):289-294. doi:10.1016/j.annonc.2019.10.022

Pasquier D, Darlix A, Louvel G, Fraisse J, Jacot W, Brain E, Petit A, Mouret-Reynier M, Goncalves A, Dalenc F, Deluche E, Fresnel J, Augereau P, Ferrero J, Geffrelot J, Fumet J-D, Lecouillard I, Cottu P, Petit T, Uwer L, Jouannaud C, Leheurteur M, Dieras V, Robain M, Mouttet-Audouard R, Bachelot T, Courtinard C Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. Eur. J. Cancer. 2020;125. doi:10.1016/j.ejca.2019.11.001

Charton E, Cuer B, Cottone F, Efficace F, Touraine C, Hamidou Z, Fiteni F, Bonnetain F, Woronoff-Lemsi M-C, Bascoul-Mollevi C, Anota A Time to deterioration in cancer randomized clinical trials for patient-reported outcomes data: a systematic review. Qual Life Res. 2020;29(4):867-878. doi:10.1007/s11136-019-02367-7

Pichard A, Marcatili S, Karam J, Constanzo J, Ladjohounlou R, Courteau A, Jarlier M, Bonnefoy N, Patzke S, Stenberg V, Coopman P, Cartron G, Navarro-Teulon I, Repetto-Llamazares A, Heyerdahl H, Dahle J, Bardiès M, Pouget J-P The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrest. Leukemia. 2020;34(5):1315-1328. doi:10.1038/s41375-019-0677-4

Alame M, Cornillot E, Cacheux V, Tosato G, Four M, Oliveira L, Gofflot S, Delvenne P, Turtoi E, Cabello-Aguilar S, Nishiyama M, Turtoi A, Martineau V, Colinge J The molecular landscape and microenvironment of salivary duct carcinoma reveal new therapeutic opportunities. 2020;10(10):4383-4394. doi:10.7150/thno.42986

Bastid J, Dejou C, Docquier A, Bonnefoy N The Emerging Role of the IL-17B/IL-17RB Pathway in Cancer. Front Immunol. 2020;11. doi:10.3389/fimmu.2020.00718

Samalin E, Adenis A TAS-118 plus oxaliplatin in advanced gastric cancer: is it worth it?. Lancet Oncol.. Jul 16, 2020. doi:10.1016/S1470-2045(20)30337-5

Khashper A, Addley H, Abourokbah N, Nougaret S, Sala E, Reinhold C T2-Hypointense Adnexal Lesions: An Imaging Algorithm. Radiographics. 2020;40(4):1200. doi:10.1148/rg.2020204005

Thierry A SARS-CoV2 may evade innate immune response, causing uncontrolled neutrophil extracellular traps formation and multi-organ failure. Clin. Sci.. 2020;134(12):1295-1300. doi:10.1042/CS20200531

Heudel P, Delaloge S, Parent D, Madranges N, Levy C, Dalenc F, Brain E, Uwer L, Augereau P, Mailliez A, Perrin C, Sablin M-P, Mouret-Reynier M-A, Vermeulin T, Eymard J-C, Petit T, Ferrero J-M, Ilie S, Goncalves A, Chenuc G, Robain M Real-world Evaluation of Oral Vinorelbine in the Treatment of Metastatic Breast Cancer: An ESME-MBC Study. Anticancer Res.. 2020;40(7):3905-3913. doi:10.21873/anticanres.14381

Nougaret S, Monsonis B, Molinari N, Piron L, Kassam Z, Cassinotto C, Guiu B Quantification of liver fat content in liver and primary liver lesions using triple-echo-gradient-echo MRI. Eur Radiol. 2020-4-22. doi:10.1007/s00330-020-06757-1

Hamyeh M, Bernex F, Larive R, Naldi A, Urbach S, Simony-Lafontaine J, Puech C, Bakhache W, Coopman P, Hendriks W, Freiss G PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness. Theranostics. 2020;10(3):1016-1032. doi:10.7150/thno.38537

Hamyeh M, Bernex F, Larive R, Naldi A, Urbach S, Simony-Lafontaine J, Puech C, Bakhache W, Solassol J, Coopman P, Hendriks W, Freiss G PTPN13 induces cell junction stabilization and inhibits mammary tumor invasiveness. 2020.

Sarrabay G, Méchin D, Salhi A, Boursier G, Rittore C, Crow Y, Rice G, Tran T-A, Cezar R, Duffy D, Bondet V, Boudhane L, Broca C, Kant B, VanGijn M, Grandemange S, Richard E, Apparailly F, Touitou I PSMB10, the last immunoproteasome gene missing for PRAAS. J. Allergy Clin. Immunol.. 2020;145(3):1015-1017.e6. doi:10.1016/j.jaci.2019.11.024

Delattre J-F, Cohen R, Henriques J, Falcoz A, Emile J-F, Fratte S, Chibaudel B, Dauba J, Dupuis O, Bécouarn Y, Bibeau F, Taieb J, Louvet C, Vernerey D, André T, Svrcek M Prognostic Value of Tumor Deposits for Disease-Free Survival in Patients With Stage III Colon Cancer: A Post Hoc Analysis of the IDEA France Phase III Trial (PRODIGE-GERCOR). JCO. 2020-03-13. doi:10.1200/JCO.19.01960

Sanchez E, Laplace-Builhé B, Mau-Them F, Richard E, Goldenberg A, Toler T, Guignard T, Gatinois V, Vincent M, Blanchet C, Boland A, Bihoreau M, Olaso R, Nephi W, Lüdecke H-J, Verheij J, Moreau-Lenoir F, Denoyelle F, Rivière J-B, Laplanche J-L, Willing M, Captier G, Apparailly F, Wieczorek D, Collet C, Djouad F, Geneviève D POLR1B and neural crest cell anomalies in Treacher Collins syndrome type 4. Genet. Med.. 2020;22(3):547-556. doi:10.1038/s41436-019-0669-9

Conte P, Schneeweiss A, Loibl S, Mamounas E, von Minckwitz G, Mano M, Untch M, Huang C-S, Wolmark N, Rastogi P, Stamatovic L, Bonnefoi H, Castro-Salguero H, Fischer H, Wahl T, Song C, Boulet T, Trask P, Geyer C Patient-reported outcomes from KATHERINE: A phase 3 study of adjuvant trastuzumab emtansine versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for human epidermal growth factor receptor 2-positive breast cancer. Cancer. 2020;126(13):3132-3139. doi:10.1002/cncr.32873

Maciel C, Bharwani N, Kubik-Huch R, Manganaro L, Otero-Garcia M, Nougaret S, Alt C, Cunha T, Forstner R MRI of female genital tract congenital anomalies: European Society of Urogenital Radiology (ESUR) guidelines. Eur Radiol. 2020-3-27. doi:10.1007/s00330-020-06750-8

Garnier S, Vendrell J, Boillot B, Karsenty G, Faure A, Blanc T, Soustelle L, Phe V, Even A, Chartier-Kastler E, Ravasse P, Poinas G, Leizour B, Costa P, Galmiche L, Iborra F, Bouali O, Solassol J, Kalfa N Malignancy after Augmentation Enterocystoplasty: A Nationwide Study of Natural History, Prognosis and Oncogene Panel Analysis. J. Urol.. 2020;204(1):136-143. doi:10.1097/JU.0000000000000752



© Institut de Recherche en Cancérologie de Montpellier - 2011 - Tous droits réservés - Mentions légales - Connexion - Conception : ID Alizés